Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study

[1] Anttila A(2010)Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma BMJ 340 c1804-365

[2] Kotaniemi-Talonen L(2010) in primary HPV DNA screening with cytology triage: randomised study within organised screening programme Nat Rev Clin Oncol 7 364-K41

[3] Leinonen M(2008)Screening: HPV testing for cervical cancer: the good, the bad, and the ugly Vaccine 26 K29-2255

[4] Hakama M(2008)Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries BMJ 337 a1754-23

[5] Laurila P(2009)Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study Int J Cancer 125 2246-498

[6] Tarkkanen J(2008)EUROGIN 2008 roadmap on cervical cancer prevention Vaccine 2008 16-1623

[7] Malila N(2006)Cervical cancer screening following prophylactic human papillomavirus vaccination Lancet 367 489-257

[8] Nieminen P(2009)Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis J Natl Cancer Inst 101 1612-555

[9] Castle PE(2010)Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting BMC Cancer 10 111-1764

[10] Cuzick J(2007)A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial) BMJ 335 28-2119

[1] Anttila A(2010)Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma BMJ 340 c1804-365

[2] Kotaniemi-Talonen L(2010) in primary HPV DNA screening with cytology triage: randomised study within organised screening programme Nat Rev Clin Oncol 7 364-K41

[3] Leinonen M(2008)Screening: HPV testing for cervical cancer: the good, the bad, and the ugly Vaccine 26 K29-2255

[4] Hakama M(2008)Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries BMJ 337 a1754-23

[5] Laurila P(2009)Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study Int J Cancer 125 2246-498

[6] Tarkkanen J(2008)EUROGIN 2008 roadmap on cervical cancer prevention Vaccine 2008 16-1623

[7] Malila N(2006)Cervical cancer screening following prophylactic human papillomavirus vaccination Lancet 367 489-257

[8] Nieminen P(2009)Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis J Natl Cancer Inst 101 1612-555

[9] Castle PE(2010)Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting BMC Cancer 10 111-1764

[10] Cuzick J(2007)A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial) BMJ 335 28-2119